Filing Details
- Accession Number:
- 0001209191-16-121073
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-17 20:36:28
- Reporting Period:
- 2016-05-13
- Filing Date:
- 2016-05-17
- Accepted Time:
- 2016-05-17 20:36:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1649989 | Oncobiologics Inc. | ONS | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1527197 | Kenneth Bahrt | C/O Oncobiologics, Inc. 7 Clarke Drive Cranbury NJ 08521 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-05-13 | 2,000 | $0.00 | 2,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Warrants (right to buy) | Acquisiton | 2016-05-13 | 1,000 | $0.00 | 1,000 | $6.60 |
Common Stock | Series B Warrants (right to buy) | Acquisiton | 2016-05-13 | 1,000 | $0.00 | 1,000 | $8.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,000 | 2017-02-18 | No | 4 | P | Direct | |
1,000 | 2018-05-18 | No | 4 | P | Direct |
Footnotes
- The reported securities are included within 2,000 Units purchased by the reporting person for $6.00 per Unit. Each Unit consists of one share of common stock, one half of a Series A warrant to purchase one share of common stock and one half of a Series B Warrant to purchase one share of common stock
- The Series A Warrants and Series B Warrants will be exercisable 30 days after 5/12/16 or on such date the underwriters separate the units, whichever date is earlier.